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Purpose. To gain insight into the host factors influencing liposome
localization at sites of bacterial infection.
Methods. In a unilateral Klebsiella pneumoniae pneumonia rat
model, capillary permeability and number of circulating leukocytes
was quantified and related to the degree of liposome target localiza-
tion.
Results. Liposome localization was highest in the hemorrhagic zone
of infection, a zone characterized by markedly increased capillary
permeability and high bacterial numbers. Both liposome localization
and capillary permeability correlated positively with severity of in-
fection. Lung instillation of other inflammatory stimuli, such as lipo-
polysaccharide or 0.1 M HCl inducing increased capillary permeabil-
ity, also promoted liposome localization. As liposomal target local-
ization in leukopenic rats was similar to that in immunocompetent
rats, contribution of circulating leukocytes seems limited. Intrapul-
monary distribution of liposomes shows that leukocytes at the target
site are involved in liposome uptake after extravasation.
Conclusions. Increased capillary permeability plays a crucial role in
liposome localization at the infected site, whereas contribution of
leukocytes is limited. These results suggest inflammatory conditions
that could benefit from liposomal drug delivery. The involvement of
leukocytes in liposome uptake at the target site could be important
information in the selection of appropriate drugs.
KEY WORDS: inflammatory response; Klebsiella pneumoniae; leu-
kocytes; liposomes; pneumonia; rat.
INTRODUCTION
Targeted delivery of antibiotics may improve antibacte-
rial therapy by increasing the concentration of the drug at the
site of infection. Liposomes have been investigated as tar-
geted drug carriers for this purpose. The avid uptake of con-
ventional liposomes after intravenous administration, by the
cells of the mononuclear phagocyte system (MPS), has been
employed to deliver substantial amounts of antibiotics selec-
tively to the cells of this system (1–2). However, the prompt
uptake by MPS-cells strongly limits the chance that conven-
tional liposomes will interact with sites of infections located
outside the major MPS-organs.
The development of liposomes coated with poly(ethyl-
ene) glycol (PEG), also known as sterically stabilized lipo-
somes (SSL), potentially permits liposomal drug delivery to
tissues beyond the MPS-cells (3–6). SSL display a reduced
affinity for the MPS, compared to liposomes lacking the PEG-
coating. It is believed that the PEG-coating reduces the in-
teraction of opsonins with the SSL surface, thereby reducing
MPS recognition and uptake. As a result SSL display a pro-
longed circulation time. In experimental models representing
a variety of inflammatory and infectious foci outside the MPS,
substantial SSL localization at the site of infection has been
demonstrated. The presence of an infectious process is essen-
tial as SSL localization in uninfected controls is limited (7–
13). Previous reports have suggested that presence of the long
circulation property is also essential to achieve significant lo-
calization at the target site (5–6,14). In addition, SSL-
encapsulated gentamicin showed improved efficacy compared
to the free drug in a rat model of Klebsiella pneumoniae pneu-
monia (15). These data warrant further investigations on SSL
as carriers of antibiotics to sites of infection beyond the cells
of the MPS.
At present, limited information is available on the host
factors that are responsible for the selective SSL localization
at inflammatory sites, compared to non-infected control or-
gans. It has been suggested that the increased capillary per-
meability at inflammatory foci allows SSL to extravasate (14).
Besides, the infiltration of inflammatory cells may actively or
passively promote SSL localization, either by taking up lipo-
somes in the circulation and subsequent infiltration into the
inflamed tissue, or by facilitating liposome extravasation as a
result of leukocyte-mediated tissue inury (16).
The present study was designed to gain more insight into
the mechanism of localization of SSL at sites of infection. In
a rat model of a unilateral pneumonia caused by Klebsiella
pneumoniae the requirement of increased capillary perme-
ability for achieving SSL localization was investigated by cor-
relating the extent of capillary permeability to the degree of
SSL localization. The correlation was also studied after lung-
instillation of other inflammatory stimuli (lipopolysaccharide
(LPS) and 0.1 M HCl). The involvement of leukocytes in SSL
extravasation was investigated by leukocyte depletion. Mi-
crsocopic visualization of colloidal-gold labeled SSL was per-
formed to obtain information on the intrapulmonary localiza-
tion of SSL after extravasation in the infected tissue.
MATERIALS AND METHODS
Animals
RP/AEur/RijHsd strain albino rats, with a specified
pathogen-free status (18–25 weeks of age, weighing 185–225
g) (Harlan, Horst, The Netherlands), were used in the experi-
ments. Rats were housed individually with free access to ster-
ilized water and SRMA chow (Hope Farms, Woerden, The
Netherlands).
Bacterial Inoculation of the Left Lung
Bacteria were inoculated in the left lung as described
previously (17). Briefly, rats were anaesthetized by an intra-
1 Department of Medical Microbiology & Infectious Diseases, Eras-
mus University Medical Center Rotterdam (EMCR), PO Box 1738,
3000 DR Rotterdam, The Netherlands.
2 Department of Pharmaceutics, Utrecht Institute for Pharmaceutical
Sciences (UIPS), Utrecht University, PO Box 80082, 3508 TB
Utrecht, The Netherlands.
3 To whom correspondence should be addressed. (e-mail: schiffelers@
kmic.fgg.eur.nl)
ABBREVIATIONS: C, consolidated zone; EI, early-infected zone;
H, hemorrhagic zone; LL, (infected) left lung; LPS, lippolysaccharide;
MPS, mononuclear phagocyte system; PEG, poly(ethylene) glycol;
RL, (uninfected) right lung; SSL, sterically stabilized liposome.
Pharmaceutical Research, Vol. 18, No. 6, 2001 Research Paper
7800724-8741/01/0600-0780$19.50/0 © 2001 Plenum Publishing Corporation
muscular injection of fluanisone and fentanyl citrate (Janssen
Animal Health, Saunderton, UK) followed by an intraperito-
neal injection of pentobarbital (Sanofi Sante´ b.v., Maassluis,
The Netherlands). The left primary bronchus was subse-
quently intubated and 0.02 ml of a saline suspension contain-
ing the indicated number of K. pneumoniae (ATCC 43816,
capsular serotype 2) was inoculated in the lower left lung
lobe. Following the inoculation, rats received an intramuscu-
lar injection of nalorphine bromide as an anesthetic antago-
nist (Onderlinge Pharmaceutische Groothandel, Utrecht, The
Netherlands).
When indicated, leukopenia was effectuated by intraper-
itoneal injection of 60 mg/kg cyclophosphamide (Sigma, St.
Louis, MO) every 4 days starting at 5 days before bacterial
inoculation, according to Leenders et al. (18). Leukopenia
was ascertained by measuring leukocyte counts in fresh blood
samples, obtained by retro-orbital bleeding just before SSL
injection. Leukocytes were counted on a Cobas Minos Stex
(Roche Haematology, Montpellier, France) using Minotrol™
16 standards (Roche Haematology, Montpellier, France) to
verify proper functioning of the instrument.
Instillation of Other Inflammatory Stimuli in the Left Lung
Rats were anesthetized and intubated as described
above. 0.02 ml of a saline solution containing 2 mg LPS (from
Escherichia coli, serotype 0111:B4 (Sigma, St. Louis, MO)) or
0.1 ml aqueous 0.1 M HCl (Fluka, Buchs, Switzerland) were
instilled in the lower left lung lobe. Nalorphine bromide was
injected as an anesthetic antagonist.
SSL Preparation
SSL were prepared as described previously (13,15). In
brief, appropriate amounts of partially hydrogenated egg
phosphatidylcholine (PHEPC) (Asahi Chemical Industry Co.
Ltd., Ibarakiken, Japan), cholesterol (Chol) (Sigma Chemical
Co., St. Louis, MO), and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[polyethylene glycol-2000] (PEG-
DSPE) (Avanti polar lipids, Alabaster, Alabama) in a molar
ratio of 1.85: 1.00:0.15, respectively, were dissolved in chloro-
form:methanol in a round bottom flask, followed by evapo-
ration of the solvent in a rotary evaporator. The lipid mixture
was dried under nitrogen for 15 min, dissolved in 2-methyl-
2-propanol (Sigma Chemical Co., St. Louis, MO) and freeze-
dried overnight. The resulting lipid film was hydrated for 2 h
in Hepes/NaCl buffer, pH 7.4 (10 mM N-[2-hydroxy ethyl]
piperazine-N8-ethane sulfonic acid (Hepes) (Sigma Chemical
Co., St. Louis, MO) and 135 mM NaCl (Merck, Darmstadt,
Germany) containing 5 mM of the chelator deferoxamine
mesylate (Desferal®) (Novartis, Basel, Switzerland). SSL
were sized by subjecting the hydrated lipid dispersion to a
sonication procedure for 8 min with an amplitude of 8 m using
a 9.5 mm probe in an MSE Soniprep 150 (Sanyo Gallenkamp
PLC, Leicester, UK).
Radiolabeling of Liposomes
Non-encapsulated deferoxamine was removed by gel fil-
tration of the SSL over a Sephadex G-50 column (Pharmacia,
Uppsalla, Sweden) using Hepes/NaCl buffer as an eluens. The
SSL were subsequently concentrated via ultracentrifugation
at 365,000 × g for 2 h at 4°C in a Beckman ultracentrifuge
L-70 (Beckman, Palo Alto, CA). SSL were labeled with 67Ga
according to Gabizon et al. (19). 67Ga-citrate (1 mCi/ml)
(Mallinckrodt Medical, Petten, The Netherlands), diluted 1:
10 in aqueous 5 mg/ml 8-hydroxyquinone (Sigma Chemical
Co., St. Louis, MO), was incubated for 1 h at 52°C to obtain
67Ga-oxine. 1 ml of this mixture was added per 1000 mmol
total lipid (TL) of SSL. 67Ga-oxine can pass the liposomal
membrane and has a high affinity for the encapsulated che-
lator deferoxamine, with the result that the radioactive label
becomes entrapped. 67Ga-deferoxamine is a suitable label for
studying intact liposomes in the circulation because it is ex-
creted rapidly via the kidneys in case it leaks from the lipo-
somes (19). Unencapsulated 67Ga was removed by gel filtra-
tion and radiolabeled SSL were concentrated by ultracentri-
fugation. Resulting specific activity was approximately 105
cpm/mmol TL.
SSL Characterization
Particle size distribution of the SSL was measured using
dynamic light scattering, detected at an angle of 90° to the
laser beam on a Malvern700 System (Malvern Instruments
Ltd., Malvern, UK). The polydispersity of the liposome popu-
lation is reported by the system as a value between 0 and 1. A
reported value of 1 indicates large variations in particle sizes,
whereas a value of 0 indicates a complete monodisperse sys-
tem. For all SSL preparations used in the experiments, the
mean liposomal size was approximately 100 nm and the poly-
dispersity was below 0.3. Phosphate concentration was deter-
mined colorimetrically according to Bartlett (20).
Bacterial Counts
At indicated time points after bacterial inoculation, rats
were sacrificed by CO2 inhalation, since this form of eutha-
nasia does not affect bacterial counts (unpublished observa-
tions). The right and left lung were excised and kept on ice
and the left lung was divided into the three distinct zones of
the lobar pneumonia: the early infected, hemorrhagic, and
consolidated zone. Lung (zones) were homogenized in 20 ml
of phosphate buffered saline (4°C), appropriate dilutions
were cultured (overnight, 37°C) on tryptone soy agar plates
(Oxoid, Basingstoke, UK) and bacterial colonies were
counted.
Evan’s Blue Dye Extravasation
Evan’s blue dye extravasation is a measure for the cap-
illary permeability (21–22) and was determined as described
previously by Zhang et al. (21). A saline suspension of Evan’s
blue dye (40 mg/kg) (Merck, Darmstadt, Germany) was in-
jected in the tail vein at indicated time points after inoculation
of the left lung. Rats were sacrificed 24 h later. A blood
sample was taken via retro-orbital puncture, the lungs were
excised and, when indicated, the left lung was divided into the
three distinct zones of the lobar pneumonia. Blood sample
volume was measured and the right lung and the three zones
of the left lung were weighed and put in 7 ml of formamide
(Sigma, St. Louis, MO) to extract the dye. Absorbance was
measured on an LKB Ultrospec Plus spectrometer (Pharma-
cia, Uppsalla, Sweden) at a wavelength of 623 nm. Standards
(0–30 mg Evan’s blue/ml) were also dissolved in formamide.
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Corrections were made for the amount of Evan’s blue present
in the blood (see SSL localization).
Lung Wet-to-Dry Weight Ratio
Another measure of capillary permeability is the wet-to-
dry weight ratio (23). Animals were sacrificed at 64 h after
bacterial inoculation, the lungs were excised and left and right
lung weight was determined. Lungs were subsequently dried
in a stove for 3 days at 70°C, the dry weight of the lungs was
determined and the wet-to-dry weight ratio was calculated.
SSL Localization
SSL (75 mmol TL/kg) were administered via the tail vein
24 h before the rats were sacrificed by an i.v. overdose of
pentobarbital, at indicated time points after inoculation of the
left lung. A blood sample was taken via retro-orbital punc-
ture, lungs were excised and, when indicated, the left lung was
divided into the three distinct zones of a lobar pneumonia.
The right lung and the three zones of the left lung were
weighed and radioactivity was counted in a Minaxi auto-
gamma 5000 gamma counter (Packard Instrument Company,
Meriden, CT) to assess the degree of localization of the SSL.
Blood content of the tissues was determined in independent
experiments with 111In-oxine labeled syngeneic erythrocytes,
as described by Kurantsin-Mills et al. (24). Labeled erythro-
cytes were injected 10 min before the animals were sacrificed.
Assuming that all erythrocytes are still present in the circu-
lation, the dilution factor of the label allows determination of
total blood volume and the blood content of the tissues of
interest. Blood content values were used to correct for the
contribution of labeled SSL in the circulation to total tissue
radioactivity.
Blood Cell-Associated SSL
To determine the amount of cell-associated SSL in the
circulation, blood samples were obtained from infected ani-
mals via retro-orbital bleeding in heparanized tubes at indi-
cated time points after injection of radioactively labeled SSL.
Blood cells (0.5 ml sample) were washed three times in 50 ml
PBS (4°C) by centrifugation at 1500 × g for 10 min (Hettich
Rotanta, Germany). Radioactivity of pellet and supernatants
was counted as described above.
Colloidal Gold-Labeling of SSL
Colloidal gold-labeled SSL were prepared as described
by Daemen et al. (25). Briefly, the lipid film was prepared as
described above. A 1.1% (w/v) aqueous solution of AuCl2
(Sigma, St. Louis, MO) was four-fold diluted with sodium
citrate (28 mM)/ potassium carbonate (7 mM) buffer, filtered
(0.2 mm), and used to hydrate the lipid film at 4°C. SSL were
prepared by multiple extrusion of the hydrated lipids through
two stacked 100 nm membranes (Nuclepore, Pleasanton,
CA). The resulting yellow SSL suspension was placed at 37°C,
after which the color of the suspension turned purple. Unen-
capsulated colloidal gold was removed by gel filtration of the
SSL suspension over a Sephacryl SF S1000 column (Pharma-
cia, Uppsalla, Sweden) using Hepes/NaCl buffer as the elu-
ens.
Localization of Colloidal-Gold Labeled SSL
Colloidal-gold labeled SSL (approx. 5 mmol TL/kg) were
injected at 40 h after bacterial inoculation of the left lung. 24
h after injection both right and left lung were excised, washed
in three changes of 2.5% buffered formaldehyde (Merck,
Darmstadt, Germany), fixed in 10% buffered formaldehyde
and embedded in paraffin. 5 mm sections were cut on a mi-
crotome and mounted on slides. Sections were deparaffinized
in two changes of xylene and hydrated. Next, colloidal gold
was silver-enhanced using a silver-enhancement kit (Sigma,
St. Louis, MO) according to the manufacturer’s instructions.
Eosin/haematoxylin was applied as a counterstain, when in-
dicated.
For the immunohistochemical staining procedure, slides
were deparaffinised and hydrated as described above. Endog-
enous peroxidase activity was blocked by incubation of slides
for 10 min in 3% H2O2 ( Merck, Darmstadt, Germany) in
methanol (Fluka, Buchs, Switzerland) followed by rinsing
with PBS. Slides were incubated with 5% goat serum for 30
min. Then 0.4 mg/ml of mouse anti-rat CD43 (Pharmingen,
San Diego, CA) was applied and slides were incubated over-
night at 4°C in a humid container. Slides were rinsed in 3
changes of PBS and the secondary polyclonal horseradish
peroxidase conjugated goat anti-mouse IgG (10 mg/ml)
(Pharmingen, San Diego, CA) was added, incubated for 30
min at room temperature and rinsed in 3 changes of PBS.
Peroxidase activity was detected using the 3-amino-9-
ethylcarbazole kit (Sigma, St. Louis, MO) according to manu-
facturers instructions.
Statistical Analysis
Indicated statistical analyses were performed using SPSS
for Windows software release 7.5.2 (Statistical Product & Ser-
vice Solutions Inc., Chicago, IL).
RESULTS
Characteristics of the Lobar K. pneumoniae Pneumonia
At 64 h after inoculation of the left lung of the rats with
106 K. pneumoniae a lobar pneumonia had developed (Fig. 1).
Three zones characteristic for this type of pneumonia can be
clearly distinguished. The consolidated zone (C) is the lower
part of the lung where the bacterial inoculum was deposited
and the infectious process started. As the active infection
gradually moves upward, the consolidated area is character-
ized by gray hepatization. Microscopic evaluation (data not
shown) indicated disintegration of alveolar walls, cellular de-
bris, limited blood flow, and the deposition of connective tis-
sue. The hemorrhagic zone (H) is the active area of the in-
fection featured by a dark red appearance. Microscopic ob-
servations (data not shown) indicate the presence of edema
fluid, a large number of bacteria, infiltrating leukocytes, and
hemorrhagic areas. The early-infected zone (EI) appears
macroscopically as normal lung tissue, however, microscopic
evaluation (data not shown) reveals the presence of bacteria
and leukocytes indicates the early involvement in the infec-
tious process. Because the three zones of the lobar pneumo-
nia can be clearly distinguished at 64 h after inoculation and
these zones showed limited variation in size and macroscopic
appearance between animals, this time-point was chosen to
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examine bacterial counts, capillary permeability, and SSL lo-
calization.
As expected, significantly higher bacterial numbers were
observed in the infected left lung (LL) per gram organ weight
compared to the uninfected right lung (RL) at 64 h after
inoculation. The distribution of the bacteria over the three
different zones of the lobar pneumonia shows that the num-
ber of bacteria was significantly higher in zone H of the pneu-
monia compared to C and EI (Fig. 2A). The localization of a
marker for capillary permeability–Evan’s blue–shows a simi-
lar pattern at 24 h after injection (Fig. 2B). A significantly
higher level of Evan’s blue was seen in the infected left lung
compared to the contralateral non-infected right lung. The
level of Evan’s blue in the right lung was comparable to the
levels measured in lungs of uninfected rats (data not shown).
Within the infected lung a significantly higher level of Evan’s
blue was present in zone H compared to C and EI. Another
measure for capillary permeability is the tissue wet-to-dry
weight ratio. The wet-to-dry weight ratio was lower for the
uninfected right lung (4.81 ± 0.05) compared to the infected
left lung (5.84 ± 0.06) (mean ± standard deviation, n 4 10) (P
< 0.0001, paired t test). Localization of 67Ga-labeled SSL
shows the same profile at 24 h after injection (Fig. 2C). Sig-
nificantly higher levels were seen in the infected left lung
compared to the right lung. Within the infected lung the high-
est level of SSL localization was seen in zone H compared to
C and EI.
Effect of Increase in Inoculum Size on Localization of SSL
and Evan’s Blue
To test whether the severity of infection has an effect on
capillary permeability and SSL localization, three different
inocula of K. pneumoniae were applied and compared to ster-
ile buffer-inoculated animals (Fig. 3). Tissues were dissected
at 48 h after inoculation as the highest inoculum already in-
duced mortality at 64 h after inoculation. Evan’s blue dye
localization and 67Ga-labeled SSL localization measured at 24
h after injection, increased with an increasing inoculum (r 4
0.91, P <0.0001, r 4 0.91, P <0.0001, both Spearman’s corre-
lation test).
Fig. 1. The consolidated (C), hemorrhagic (H), and early infected
(EI) zone of an acute lobar pneumonia in the left lung of a rat at 64
h after inoculation of the left lung with 106 K. pneumoniae.
Fig. 2. Localization of bacteria (A), Evan’s blue (B), and 67Ga-
labeled SSL (C) in right lung (RL) and infected left lung (LL) (closed
bars) (n 4 6, mean ± standard deviation). Localization within the LL
in the consolidated (C), hemorrhagic (H), and early infected (EI)
zone of the lobar pneumonia (open bars) (n 4 6, mean ± standard
deviation). *P <0.05, **P <0.01, ***P <0.001, left lung compared to
right lung (paired t test), consolidated zone and early infected zone
each compared to hemorrhagic zone (repeated measures ANOVA
corrected for multiple comparisons by the Bonferroni method). Tis-
sues were dissected at 64 h after inoculation of the left lung with 106
K. pneumoniae, at 24 h after injection of liposomes and Evan’s blue.
Fig. 3. Effect of increasing K. pneumoniae inoculum on degree of
localization of SSL (open bars) and Evan’s blue (closed bars) in the
inoculated left lung (LL) (n 4 6, mean ± standard deviation). Tissues
were dissected at 48 h after bacterial inoculation of the left lung, at 24
h after injection of liposomes and Evan’s blue.
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Effect of Local Administration of LPS and HCl on Left
Lung Localization of SSL and Evan’s Blue
LPS, a component of the Gram-negative bacterial cell
wall, has been shown to increase capillary permeability in
lung tissue after local administration (26). To test whether an
increase in capillary permeability induced by LPS in the ab-
sence of living bacteria also produces increased 67Ga-labeled
SSL localization, 2 mg LPS was inoculated in the left lung.
After instillation of the LPS a significantly increased localiza-
tion of 67Ga-labeled SSL and Evan’s blue in the lung was
noted at 24 h after injection (Fig. 4). Similarly, inoculation of
the left lung with 0.1 ml 0.1 M HCl, a model for adult respi-
ratory distress syndrome featured by an increased capillary
permeability (23), resulted in an increased localization of
67Ga-labeled SSL and Evan’s blue at 24 h after injection
(Fig. 4).
Effect of Leukocytes on Localization of SSL
To investigate whether SSL are taken up by circulating
leukocytes, 67Ga-labeled SSL were injected i.v. Blood
samples were washed three times in PBS by centrifugation.
The amount of cell-associated radioactivity was determined.
In blood samples obtained at 1 h, 4 h, and 24 h after SSL
injection 0.28 ± 0.12%, 0.35 ± 0.16%, and 0.17 ± 0.08% of the
recovered radioactivity was pelletable with the blood cell
fraction, respectively (mean ± standard deviation, n 4 3).
To establish whether extravasation of inflammatory cells
is a key factor contributing to SSL localization in the left lung,
the number of leukocytes in the circulation was reduced by
i.p. injections of cyclophosphamide. As a result of the cyclo-
phosphamide treatment, the number of leukocytes in the
blood was reduced 6-fold from 5.8 × 109 ± 1 × 109 for the
buffer treated controls to 1 × 109 ± 8 × 108 for the cyclophos-
phamide treated rats (mean ± standard deviation, n 4 3) (P
<0.01, unpaired t test). Tissues were dissected at 48 h after
inoculation as the infection produced mortality in the leuko-
penic animals already at 64 h after inoculation. At 24 h after
injection of 67Ga-labeled SSL, SSL localization in the infected
left lung of either leukopenic animals or animals with an in-
tact host defense was significantly higher compared to 67Ga-
labeled SSL localization in the lungs of uninfected animals
(Fig. 5). Cyclophosphamide treatment did not result in a sig-
nificant difference in the degree of 67Ga-labeled SSL local-
ization in infected animals.
Microscopic Evaluation of Colloidal Gold-Labeled SSL
Within the Infected Site
Localization of SSL in infected left lung and uninfected
right lung tissue was visualized using silver-enhancement of
colloidal gold-labeled SSL. Figure 6A and B show dense clus-
ters of silver-enhanced colloidal gold in the connective tissue
surrounding the primary bronchus and major bronchioles of
the infected left lung. These clusters were not observed in the
uninfected right lung. Magnification of these clusters show
that the silver-enhanced colloidal-gold is present in mono-
nuclear cells (Fig. 6C). These cells stained positive immuno-
Fig. 4. Localization of liposomes (open bars) and Evan’s blue (closed
bars) in right lung (RL) and left lung (LL) of rats inoculated with
buffer (A), 2 mg LPS per left lung (B), and 0.1 ml 0.1 M HCl per left
lung (C). Liposomes and Evan’s blue were injected 15 min after
inoculation. Tissues were dissected at 24 h after injection of liposomes
and Evan’s blue. (n 4 6, mean ± standard deviation). *P <0.05, **P
<0.01, ***P <0.001 compared to right lung (paired t test).
Fig. 5. Localization of liposomes in the left lung of uninfected rats
with intact host defense (1), infected rats with intact host defense (2),
and infected leukopenic rats (3) (n 4 6, mean ± standard deviation).
Tissues were dissected at 48 h after inoculation of the left lung in-
oculated with 106 K. pneumoniae, at 24 h after injection of liposomes
and Evan’s blue. **P <0.01 infected rats compared to uninfected rats.
No significant differences were noted between leukopenic infected
rats and infected rats with an intact host defense (ANOVA corrected
for multiple comparisons by the Bonferroni method).
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histochemically for CD43 (Fig. 6D). One aspect of SSL local-
ization that could only be clearly visualized in slides unstained
or with just a very light counterstain is the presence of SSL in
and around alveolar capillaries. Micrographs show silver
granula in and around the capillaries in the alveolar walls,
most prominent in the hemorrhagic zone of infected left lung
tissue (Fig. 6E,F). Silver granula were not seen surrounding
capillaries or alveolar walls in the uninfected right lung tissue.
Fig. 6. Localization of colloidal gold-labeled liposomes in infected left lung tissue. A. Presence of silver-enhanced colloidal gold-labeled SSL
in large clusters (arrows) in the connective tissue surrounding the large bronchioles and blood vessels (asterisk). Inflamed alveolar spaces with
high numbers of leukocytes surround the connective tissue (circles). Counterstain haematoxylin/eosin. Bar 4 1125 mm. B. Magnification of
clusters, as shown in A. Separate silver-enhanced colloidal gold-labeled clusters (arrows) can be clearly distinguished from surrounding tissue,
in which a bronchiolar lumen (circle) and blood vessels (asterisks) are identified. Counterstain haematoxylin/eosin. Bar 4 450 mm. C.
Magnification of clusters, as shown in B. Clusters appear intracellular silver-enhanced colloidal-gold in a mononuclear cell. Bar 4 45 mm.
D. Positive immunohistochemical staining for CD43 of cells containing silver-enhanced colloidal gold-labeled SSL (closed arrows). Not all
positively stained leukocytes show colloidal-gold accumulation (open arrow). Peroxidase activity was detected by 3 amino-9-ethylcarbazole.
Bar 4 45 mm. E. Localization of silver-enhanced colloidal gold-labeled SSL in and around alveolar capillaries in the alveolar walls,
surrounding the alveolar spaces (asterisks) in a hemorrhagic area of the infected lung. Clustered silver-enhanced colloidal-gold may indicate
cellular uptake (arrows). Lightly counterstained with haematoxylin/eosin. Bar 4 450 mm. F. Localization of silver-enhanced colloidal
gold-labeled SSL (arrows) in and around alveolar capillaries in the alveolar walls. No counterstain. Bar 4 45 mm.
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DISCUSSION
Preferential localization of SSL at sites of infection or
inflammation that have developed outside the MPS has been
reported by a number of investigators (7–13). Which host
factors contribute to selective extravasation of SSL at infec-
tious or inflammatory foci is not clear. In the present study,
the involvement of increased capillary permeability and the
role of inflammatory cells in the selective localization of SSL
in bacterially infected lungs was studied in a rat model of
unilateral pneumonia caused by K. pneumoniae.
Three distinct zones of infection characterize the lobar
unilateral K. pneumoniae pneumonia: the early infected,
hemorrhagic, and consolidated zone. When the distribution of
bacteria was studied at 64 h after inoculation, a higher num-
ber of bacteria was present in the inoculated left lung com-
pared to the right lung. Within the infected left lung, the
highest number of bacteria is present in the active hemor-
rhagic zone of the infection compared to the consolidated
zone and early-infected zone. It is shown that the high num-
ber of bacteria in the hemorrhagic zone of the infected lung
correlates with a pronounced inflammatory response, fea-
tured by a significantly increased capillary permeability as
reflected by Evan’s blue dye levels and lung wet-to-dry weight
ratio. Furthermore, by raising the bacterial inoculum and
thereby aggravating the severity of the infection, the increase
in capillary permeability is enlarged. The increase in capillary
permeability was invariably seen along with a proportional
increase in SSL localization illustrating that capillary perme-
ability is an important determinant for SSL extravasation.
The observed correlation between capillary permeability and
SSL extravasation is in line with studies showing preferential
accumulation of SSL in tumor tissue, possessing angiogenic
blood vessels exhibiting increased permeability, as has been
reviewed (4–6). It also supports the observation of Klimuk et
al. that increase in vascular permeability and liposome local-
ization occur simultaneously in a model of delayed type hy-
persensitivity (8).
Increased capillary permeability has been described after
intratracheal administration of LPS and HCl in rats (23,26).
Also in our experiments, both inflammatory stimuli promoted
an increase in capillary permeability as well as SSL localiza-
tion. Apparently, the nature of the inflammatory stimulus is
not important for SSL localization as long as a sufficient in-
crease in capillary permeability is effectuated. Preferential
SSL localization at the target site has been demonstrated in a
wide variety of models of experimental inflammation and in-
fection, including pathology as a result of administration of
guinea-pig spinal cord (allergic encephalomyelitis) (7), 2,4-
dinitrofluorobenzene (delayed type hypersensitivity) (8), tri-
nitrobenzene sulfonic acid (acute colitis) (9), sodium-
morrhuate and Staphylococcus aureus (osteomyelitis) (10),
Mycobacterium butyricum (adjuvant arthritis) (11), turpen-
tine or Staphylococcus aureus (focal infection or inflamma-
tion) (12), and K. pneumoniae (unilateral pneumonia) (13).
These findings strongly suggest that the etiology or location of
the pathological process is not decisive for achieving SSL lo-
calization. Instead, increased capillary permeability, as part of
the inflammatory response is likely to be the decisive param-
eter.
Previous studies in models of hypersensitivity, colitis, and
encephalomyelitis have reported preferential SSL localization
as well as leukocyte influx at the site of inflammation (7–9).
Also in the present model, the inflammatory response in-
volves leukocyte infiltration. It has been suggested that there
is a correlation between SSL and leukocyte localization (14).
In the present study, it is shown that the amount of cell-
associated SSL-encapsulated radioactivity in the circulation is
negligible. In addition, a 6-fold reduction of the number of
leukocytes in the circulation by cyclophosphamide injections
did not result in a reduced degree of SSL localization in the
infected lung compared to rats with normal levels of leuko-
cytes. In addition, Dams et al. showed that SSL still localized
preferentially at sites of infection in granulocytopenic rats
(27). These results strongly suggest that the contribution of
circulating leukocytes to SSL localization at the site of infec-
tion is limited. An important implication would be that lipo-
somal drug delivery could also be beneficial to leukopenic
patients. These patients are highly susceptible to infections
that are difficult to treat as a result of a reduced support by
the host defense (28).
Microscopic evaluation of silver-enhanced colloidal gold-
labeled SSL in lung tissue showed that SSL could be visual-
ized principally in the infected left lung. In the left lung, SSL
were present in dense clusters in the connective tissue sur-
rounding the primary bronchus and main bronchioles. These
clusters appeared to be uptake by CD43-positive mono-
nuclear leukocytes. SSL were also seen surrounding capillar-
ies in alveolar walls, especially in the hemorrhagic zone of
infection, supporting the observation that increased capillary
permeability allows liposome extravasation. To our knowl-
edge, the localization of SSL around capillaries and liposome
uptake at the site of bacterial infection by leukocytes has not
been demonstrated before. Our results are in line with studies
obtained in other models showing that SSL are taken up by
inflammatory cells present at the inflamed tissue. In the FSN
mouse (having a gene mutation producing inflammatory le-
sions resembling psoriasis) (29), in mice having been injected
with substance P (30), and in mice overexpressing the HIV tat
gene showing lesions resembling Kaposi’s sarcoma (31), se-
lective SSL localization at the target site was demonstrated
together with uptake of colloidal gold labeled SSL by phago-
cytic cells. It is tempting to speculate that phagocytic cells at
the pathological site are involved in the processing of SSL and
release of encapsulated agents. Still, the quantitative contri-
bution of SSL uptake by local phagocytes to the fate of SSL
localizing within the infected area remains unclear.
In conclusion, our observations indicate that the selec-
tivity of SSL localization is a result of the local inflammatory
response, as the locally increased capillary permeability
seems decisive for SSL localization. The localization process
appears independent of the nature of the inflammatory stimu-
lus and number of circulating leukocytes. Microscopic obser-
vations indicate that phagocytes are to a certain extent in-
volved in SSL uptake at the site of infection. In addition,
extravasation of liposomes is observed in the alveolar walls.
Further elucidation of the processes that determine the fate of
SSL after target site localization, may help to design SSL-
antibiotic formulations with increased antibacterial activity.
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